Menu
Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 10
Clinical Pharmacology: Advances and Applications
ISSN: 1179-1438
- View all (269)
- Volume 16, 2024 (2)
- Volume 15, 2023 (12)
- Volume 14, 2022 (12)
- Volume 13, 2021 (27)
- Volume 12, 2020 (28)
- Volume 11, 2019 (16)
- Volume 10, 2018 (19)
- Volume 9, 2017 (19)
- Volume 8, 2016 (20)
- Volume 7, 2015 (14)
- Volume 6, 2014 (23)
- Volume 5, 2013 (30)
- Volume 4, 2012 (11)
- Volume 3, 2011 (7)
- Volume 2, 2010 (28)
- Volume 1, 2009 (1)
Archive: Volume 10, 2018
Correlation between measured and calculated free phenytoin serum concentration in neurointensive care patients with hypoalbuminemia
Javadi SS, Mahjub R, Taher A, Mohammadi Y, Mehrpooya M
Clinical Pharmacology: Advances and Applications 2018, 10:183-190
Published Date: 13 December 2018
Treatment of acne with a combination of propolis, tea tree oil, and Aloe vera compared to erythromycin cream: two double-blind investigations
Mazzarello V, Donadu MG, Ferrari M, Piga G, Usai D, Zanetti S, Sotgiu MA
Clinical Pharmacology: Advances and Applications 2018, 10:175-181
Published Date: 13 December 2018
Species difference in paclitaxel disposition correlated with poor pharmacological efficacy translation from mice to humans
Li YF, Zhang C, Zhou S, He M, Zhang H, Chen N, Li F, Luan X, Pai M, Yuan H, Sun D, Li Y
Clinical Pharmacology: Advances and Applications 2018, 10:165-174
Published Date: 8 November 2018
Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects
Frost C, Shenker A, Jhee S, Yu Z, Wang J, Bragat A, Pursley J, LaCreta F
Clinical Pharmacology: Advances and Applications 2018, 10:153-163
Published Date: 24 October 2018
12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus
Perna S, Mainardi M, Astrone P, Gozzer C, Biava A, Bacchio R, Spadaccini D, Solerte SB, Rondanelli M
Clinical Pharmacology: Advances and Applications 2018, 10:141-151
Published Date: 9 October 2018
The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells
Al-Keilani MS, Alzoubi KH, Jaradat SA
Clinical Pharmacology: Advances and Applications 2018, 10:135-140
Published Date: 9 October 2018
Mechanisms and the clinical relevance of complex drug–drug interactions
Roberts AG, Gibbs ME
Clinical Pharmacology: Advances and Applications 2018, 10:123-134
Published Date: 27 September 2018
Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
Oh F, Todhunter D, Taras E, Vallera DA, Borgatti A
Clinical Pharmacology: Advances and Applications 2018, 10:113-121
Published Date: 26 September 2018
Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan
Shigematsu T, Shimazaki R, Fukagawa M, Akizawa T
Clinical Pharmacology: Advances and Applications 2018, 10:101-111
Published Date: 11 September 2018
A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension
Li Y, Liu L, Huang L, Wang X, Hoffmann M, Reyes J, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2018, 10:89-99
Published Date: 19 July 2018
Safety and neutralizing rabies antibody in healthy subjects given a single dose of rabies immune globulin caprylate/chromatography purified
Hanna K, Cruz MC, Mondou E, Corsi E, Vandeberg P
Clinical Pharmacology: Advances and Applications 2018, 10:79-88
Published Date: 26 June 2018
Pharmacokinetic evaluation of D-ribose after oral and intravenous administration to healthy rabbits
Alzoubi KH, Ismail ZB, AL-Essa MK, Alshogran OY, Abutayeh RF, Abu-Baker N
Clinical Pharmacology: Advances and Applications 2018, 10:73-78
Published Date: 12 June 2018
A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]
Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, LaCreta F
Clinical Pharmacology: Advances and Applications 2018, 10:71-72
Published Date: 11 June 2018
Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications
Tahaineh L, Edaily SM, Gharaibeh SF
Clinical Pharmacology: Advances and Applications 2018, 10:63-70
Published Date: 18 May 2018
Distribution of pomalidomide into semen of healthy male subjects after multiple doses
Li Y, Wang X, Liu L, Reyes J, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2018, 10:53-62
Published Date: 7 May 2018
Pharmacokinetic equivalence study of nonsteroidal anti-inflammatory drug etoricoxib
Tjandrawinata RR, Setiawati A, Nofiarny D, Susanto LW, Setiawati E
Clinical Pharmacology: Advances and Applications 2018, 10:43-51
Published Date: 6 April 2018
Safinamide: an add-on treatment for managing Parkinson’s disease
Müller T
Clinical Pharmacology: Advances and Applications 2018, 10:31-41
Published Date: 5 April 2018
Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy
Al-Keilani MS, Alsmadi DH, Darweesh RS, Alzoubi KH
Clinical Pharmacology: Advances and Applications 2018, 10:23-29
Published Date: 5 March 2018
A review of the pharmacology and clinical efficacy of brivaracetam
Klein P, Diaz A, Gasalla T, Whitesides J
Clinical Pharmacology: Advances and Applications 2018, 10:1-22
Published Date: 19 January 2018